US2020397459A1PendingUtilityA1

Medicant delivery device

Assignee: GYRUS ACMI INCPriority: Nov 8, 2018Filed: Sep 3, 2020Published: Dec 24, 2020
Est. expiryNov 8, 2038(~12.3 yrs left)· nominal 20-yr term from priority
A61B 17/3478A61B 1/2676A61B 17/3205A61B 17/320016
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An example medical instrument for creating tracks within target tissue. Medicants could be injected into these tracks for diffusion into the surrounding tissue. An exemplary medical device includes a first tissue penetrating device, a second tissue penetrating device and a handle. The handle includes a first component connected to the first tissue penetrating device and a second component connected to the second tissue penetrating device. When the second component is at a first position relative to the first component, the second tissue penetrating device is in a non-track creation configuration. When the second component is at a second position relative to the first component, the second tissue penetrating device is in a track creation configuration. The second tissue penetrating device is slidably received within the first tissue penetrating device.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A medical device comprising:
 a first tissue penetrating device;   a second tissue penetrating device configured to extend from the first penetrating device, in an extended state the second tissue penetrating device forms a coil, in a retracted state the second tissue penetrating device conforms to the first tissue penetrating device; and   a handle comprising:
 a first component connected to the first tissue penetrating device; 
 a second component connected to the second tissue penetrating device; and 
 a fluid delivery component configured to allow fluid to pass into the first tissue penetrating device, 
 wherein when the second component is at a first position relative to the first component, the second tissue penetrating device is in an undeployed configuration, 
 wherein when the second component is at a second position relative to the first component, the second tissue penetrating device is in a deployed configuration. 
   
     
     
         2 . The medical device of  claim 1 , wherein the first and second tissue penetrating devices are configured to repeatedly allow the second tissue penetrating device to extend from and retract into the first tissue penetrating device. 
     
     
         3 . A method comprising:
 a) inserting a hollow needle into a target;   b) deploying a coil from within the hollow needle;   c) retracting the coil back into the hollow needle; and   d) advancing medicant solution through the hollow needle to the target.   
     
     
         4 . The method of  claim 3 , further comprising:
 before d) performing the following one or more times;
 at least one of retracting or advancing the hollow needle into a different location of the target; and 
 repeating b) and c). 
   
     
     
         5 . The method of  claim 3 , wherein the coil is in a non-coiled configuration when within the hollow needle.

Join the waitlist — get patent alerts

Track US2020397459A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.